Ultrasound Assessment of DILAPAN-S
Longitudinal Ultrasound Evaluation of Dilapan-S During Cervical Ripening
1 other identifier
observational
44
1 country
1
Brief Summary
The goal of this observational prospective study is to assess the change in Dilapan-S rod diameters using transvaginal ultrasound over a period of 12 hours in term women undergoing induction of labor.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 17, 2020
CompletedFirst Posted
Study publicly available on registry
August 28, 2020
CompletedStudy Start
First participant enrolled
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedAugust 9, 2023
August 1, 2023
9 months
August 17, 2020
August 7, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Diameter change of Dilapan-S
Rod diameters of Dilapan-S rods were measured via transvaginal ultrasound at 3,6,8, and 12 hours after placement.
12 hours
Secondary Outcomes (2)
Gauze placement and rod diameter
12 hours
Patient satisfaction
12 hours
Study Arms (2)
Pregnant individuals with Dilapan-S only
22 women received Dilapan-S rods without gauze at start of induction.
Pregnant individuals with Dilapan-S plus gauze placement
22 women received Dilapan-S rods with 1 gauze at start of induction.
Interventions
Eligibility Criteria
Pregnant individuals at term undergoing labor induction at single academic institution.
You may qualify if:
- Pregnant individuals at gestational age 37 weeks or greater.
- Scheduled medical or elective induction at Sentara Norfolk General Hospital.
- Live, singleton IUP.
- Vertex presentation.
- Intact membranes.
- Bishop score of 6 or less.
You may not qualify if:
- Unwilling or unable to provide consent.
- Intrauterine fetal demise
- Contraindications to vaginal delivery.
- BMI \> 45
- Vaginal bleeding
- Clinically evident genital tract infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eastern Virginia Medical School
Norfolk, Virginia, 23501, United States
Related Publications (10)
Chen W, Xue J, Peprah MK, Wen SW, Walker M, Gao Y, Tang Y. A systematic review and network meta-analysis comparing the use of Foley catheters, misoprostol, and dinoprostone for cervical ripening in the induction of labour. BJOG. 2016 Feb;123(3):346-54. doi: 10.1111/1471-0528.13456. Epub 2015 Nov 5.
PMID: 26538408BACKGROUNDGrobman WA, Rice MM, Reddy UM, Tita ATN, Silver RM, Mallett G, Hill K, Thom EA, El-Sayed YY, Perez-Delboy A, Rouse DJ, Saade GR, Boggess KA, Chauhan SP, Iams JD, Chien EK, Casey BM, Gibbs RS, Srinivas SK, Swamy GK, Simhan HN, Macones GA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Labor Induction versus Expectant Management in Low-Risk Nulliparous Women. N Engl J Med. 2018 Aug 9;379(6):513-523. doi: 10.1056/NEJMoa1800566.
PMID: 30089070BACKGROUNDAmerican College of Obstetricians and Gynecologists. Induction of Labor. ACOG Practice Bulletin No. 107. August 2009.
BACKGROUNDSaad AF, Villarreal J, Eid J, Spencer N, Ellis V, Hankins GD, Saade GR. A randomized controlled trial of Dilapan-S vs Foley balloon for preinduction cervical ripening (DILAFOL trial). Am J Obstet Gynecol. 2019 Mar;220(3):275.e1-275.e9. doi: 10.1016/j.ajog.2019.01.008. Epub 2019 Feb 18.
PMID: 30790569BACKGROUNDDrunecky T, Reidingerova M, Plisova M, Dudic M, Gdovinova D, Stoy V. Experimental comparison of properties of natural and synthetic osmotic dilators. Arch Gynecol Obstet. 2015 Aug;292(2):349-54. doi: 10.1007/s00404-015-3623-3. Epub 2015 Jan 25.
PMID: 25618749BACKGROUNDGupta J, Chodankar R, Baev O, Bahlmann F, Brega E, Gala A, Hellmeyer L, Hruban L, Maier J, Mehta P, Murthy A, Ritter M, Saad A, Shmakov R, Suneja A, Zahumensky J, Gdovinova D. Synthetic osmotic dilators in the induction of labour-An international multicentre observational study. Eur J Obstet Gynecol Reprod Biol. 2018 Oct;229:70-75. doi: 10.1016/j.ejogrb.2018.08.004. Epub 2018 Aug 3.
PMID: 30107363BACKGROUNDChambers DG, Willcourt RJ, Laver AR, Baird JK, Herbert WY. Comparison of Dilapan-S and laminaria for cervical priming before surgical pregnancy termination at 17-22 weeks' gestation. Int J Womens Health. 2011;3:347-52. doi: 10.2147/IJWH.S25551. Epub 2011 Oct 20.
PMID: 22114527BACKGROUNDAbuhamad, A. Ultrasound in Obstetrics and Gynecology: A Practical Approach. Chapter 1: Basic Physical Principles of Medical Ultrasound. 2014.
BACKGROUNDSung YT, Wu JS. The Visual Analogue Scale for Rating, Ranking and Paired-Comparison (VAS-RRP): A new technique for psychological measurement. Behav Res Methods. 2018 Aug;50(4):1694-1715. doi: 10.3758/s13428-018-1041-8.
PMID: 29667082BACKGROUNDKliger M, Stahl S, Haddad M, Suzan E, Adler R, Eisenberg E. Measuring the Intensity of Chronic Pain: Are the Visual Analogue Scale and the Verbal Rating Scale Interchangeable? Pain Pract. 2015 Jul;15(6):538-47. doi: 10.1111/papr.12216. Epub 2014 Apr 16.
PMID: 24735056BACKGROUND
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Elizabeth Seagraves, DO
Eastern Virginia Medical School MFM Fellowship
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Maternal Fetal Medicine Fellow
Study Record Dates
First Submitted
August 17, 2020
First Posted
August 28, 2020
Study Start
October 1, 2020
Primary Completion
June 30, 2021
Study Completion
June 30, 2021
Last Updated
August 9, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- 1-2 months after conclusion of study
- Access Criteria
- Results and statistical analysis will be available at the conclusion of the study
Study protocol, statistical analysis plan, informed consent form were made available. Results from the study will be available to the manufacturer (Medicem) after statistical analysis is completed and will not be shared with the manufacturer during study execution. The manufacturer company will not be involved in data analysis and all data will be independently analyzed by HADSI. The results of this study will be presented at conferences or published in a peer-review journal.